Company profile
VIOLET Pharmaceuticals
Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies
- Industry
- Pharmaceutical Manufacturing
- Employees
- 2
- Headquarters
- Barcelona
- Office locations
- 1
VIOLET Pharmaceuticals company summary
VIOLET Pharmaceuticals is a company in the Pharmaceutical Manufacturing industry, headquartered in Barcelona. On LinkedIn the company has around 2 employees. Its listed specialties include mRNA therapy, Antigen Presentation Machinery, Lymphocyte Enhancing Therapy, gene therapy, Adoptive Cell Transfer.
What technology does VIOLET Pharmaceuticals use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About VIOLET Pharmaceuticals
VIOLET Pharmaceuticals is a preclinical stage biopharma company developing a First-in-Class mRNA therapy against metastatic cancers. The company develops nanotherapies improving immunotherapies’ efficiency and approved indications (e.g. Immune Checkpoints Inhibitors (ICI)) by increasing the whole Antigen Presentation Machinery (APM) in tumor cells. Our mRNA technology is backed by Top-Notch science published in leading journals such as Nature Cell Biology and Nature Cancer, and has a strong IP position (3 patents). We achieved radical complete responses with our mRNA NanoTherapy in combination with ICI in several breast cancer tumors and metastasis models. Our mRNA specifically modulates the whole Antigen Presentation Machinery which determines immune detection (tumor visibility) and immunotherapy response. There are currently no specific APM-modulating therapies on the market, only competitors with indirect APM modulation. Therefore, our patented mRNA therapy emerges as a critical therapeutic partner to make tumor cells visible and vulnerable to immunotherapies. VIOLET Pharmaceuticals : Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies
Specialties
Where is VIOLET Pharmaceuticals located?
VIOLET Pharmaceuticals lists 1 location.
Compare companies similar to VIOLET Pharmaceuticals
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
VIOLET Pharmaceuticals violet-pharmaceuticals.com | Pharmaceutical Manufacturing | 2 | - | Barcelona |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about VIOLET Pharmaceuticals
What does VIOLET Pharmaceuticals do?
VIOLET Pharmaceuticals is a preclinical stage biopharma company developing a First-in-Class mRNA therapy against metastatic cancers. The company develops nanotherapies improving immunotherapies’ efficiency and approved indications (e.g. Immune Checkpoints Inhibitors (ICI)) by increasing the whole Antigen Presentation Machinery (APM) in tumor cells. Our mRNA technology is backed by Top-Notch science published in leading journals such as Nature Cell Biology and Nature Cancer, and has a strong IP position (3 patents). We achieved radical complete responses with our mRNA NanoTherapy in combination with ICI in several breast cancer tumors and metastasis models. Our mRNA specifically modulates the whole Antigen Presentation Machinery which determines immune detection (tumor visibility) and immunotherapy response. There are currently no specific APM-modulating therapies on the market, only competitors with indirect APM modulation. Therefore, our patented mRNA therapy emerges as a critical therapeutic partner to make tumor cells visible and vulnerable to immunotherapies. VIOLET Pharmaceuticals : Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies
How many employees does VIOLET Pharmaceuticals have?
VIOLET Pharmaceuticals has around 2 employees on LinkedIn.
Where is VIOLET Pharmaceuticals headquartered?
VIOLET Pharmaceuticals is headquartered in Barcelona.
Build a lead list from companies like VIOLET Pharmaceuticals
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.